Invention Grant
- Patent Title: Methods and apparatus for renal neuromodulation
-
Application No.: US17347179Application Date: 2021-06-14
-
Publication No.: US11963714B2Publication Date: 2024-04-23
- Inventor: Mark E. Deem , Hanson S. Gifford, III , Denise Zarins , Douglas Sutton , Erik Thai , Mark Gelfand , Howard R. Levin
- Applicant: Medtronic Ireland Manufacturing Unlimited Company
- Applicant Address: IE Dublin
- Assignee: Medtronic Ireland Manufacturing Unlimited Company
- Current Assignee: Medtronic Ireland Manufacturing Unlimited Company
- Current Assignee Address: IE Dublin
- Agency: Shumaker & Sieffert, P.A.
- The original application number of the division: US11129765 2005.05.13
- Main IPC: A61B18/14
- IPC: A61B18/14 ; A61B8/08 ; A61B8/12 ; A61B18/00 ; A61B18/12 ; A61B18/18 ; A61M5/14 ; A61M25/00 ; A61N1/04 ; A61N1/05 ; A61N1/18 ; A61N1/20 ; A61N1/32 ; A61N1/36 ; A61N5/00 ; A61N7/00

Abstract:
Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for percutaneous intravascular delivery of pulsed electric fields to achieve such neuromodulation.
Public/Granted literature
- US20210298826A1 METHODS AND APPARATUS FOR RENAL NEUROMODULATION Public/Granted day:2021-09-30
Information query